163 related articles for article (PubMed ID: 15578730)
1. p16(INK4a) promoter methylation and protein expression in breast fibroadenoma and carcinoma.
Di Vinci A; Perdelli L; Banelli B; Salvi S; Casciano I; Gelvi I; Allemanni G; Margallo E; Gatteschi B; Romani M
Int J Cancer; 2005 Apr; 114(3):414-21. PubMed ID: 15578730
[TBL] [Abstract][Full Text] [Related]
2. Methylation of CpG islands of p16(INK4a) and cyclinD1 overexpression associated with progression of intraductal proliferative lesions of the breast.
Liu T; Niu Y; Feng Y; Niu R; Yu Y; Lv A; Yang Y
Hum Pathol; 2008 Nov; 39(11):1637-46. PubMed ID: 18657295
[TBL] [Abstract][Full Text] [Related]
3. [Methylation and expression of gene p16INK4a and RB in breast carcinoma].
Zhao YF; Shen SP; Jiang JY; Geng H; Guo JG; Xie LP
Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):377-81. PubMed ID: 21055153
[TBL] [Abstract][Full Text] [Related]
4. Expression of the p16(INK4a) gene product, methylation of the p16(INK4a) promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions.
Breuer RH; Snijders PJ; Sutedja GT; Sewalt RG; Otte AP; Postmus PE; Meijer CJ; Raaphorst FM; Smit EF
Lung Cancer; 2005 Jun; 48(3):299-306. PubMed ID: 15892997
[TBL] [Abstract][Full Text] [Related]
5. Relationship between expression and methylation status of p16INK4a and the proliferative activity of different areas' tumour cells in human colorectal cancer.
Jie G; Zhixiang S; Lei S; Hesheng L; Xiaojun T
Int J Clin Pract; 2007 Sep; 61(9):1523-9. PubMed ID: 17537196
[TBL] [Abstract][Full Text] [Related]
6. p16(INK4a) promoter methylation and 9p21 allelic loss in colorectal carcinomas: relation with immunohistochemical p16(INK4a) expression and with tumor budding.
Prall F; Ostwald C; Weirich V; Nizze H
Hum Pathol; 2006 May; 37(5):578-85. PubMed ID: 16647956
[TBL] [Abstract][Full Text] [Related]
7. Morphologically normal-appearing mammary epithelial cells obtained from high-risk women exhibit methylation silencing of INK4a/ARF.
Bean GR; Bryson AD; Pilie PG; Goldenberg V; Baker JC; Ibarra C; Brander DM; Paisie C; Case NR; Gauthier M; Reynolds PA; Dietze E; Ostrander J; Scott V; Wilke LG; Yee L; Kimler BF; Fabian CJ; Zalles CM; Broadwater G; Tlsty TD; Seewaldt VL
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6834-41. PubMed ID: 18006786
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age.
Liau JY; Liao SL; Hsiao CH; Lin MC; Chang HC; Kuo KT
Hum Pathol; 2014 Mar; 45(3):533-9. PubMed ID: 24440092
[TBL] [Abstract][Full Text] [Related]
9. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G
Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
[TBL] [Abstract][Full Text] [Related]
10. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis.
Zhu R; Li BZ; Li H; Ling YQ; Hu XQ; Zhai WR; Zhu HG
Pathol Int; 2007 Jun; 57(6):328-36. PubMed ID: 17539963
[TBL] [Abstract][Full Text] [Related]
11. Relationships among folate, alcohol consumption, gene variants in one-carbon metabolism and p16INK4a methylation and expression in healthy breast tissues.
Llanos AA; Dumitrescu RG; Brasky TM; Liu Z; Mason JB; Marian C; Makambi KH; Spear SL; Kallakury BV; Freudenheim JL; Shields PG
Carcinogenesis; 2015 Jan; 36(1):60-7. PubMed ID: 25344837
[TBL] [Abstract][Full Text] [Related]
12. Electron microscopy evidence that cytoplasmic localization of the p16(INK4A) "nuclear" cyclin-dependent kinase inhibitor (CKI) in tumor cells is specific and not an artifact. A study in non-small cell lung carcinomas.
Evangelou K; Bramis J; Peros I; Zacharatos P; Dasiou-Plakida D; Kalogeropoulos N; Asimacopoulos PJ; Kittas C; Marinos E; Gorgoulis VG
Biotech Histochem; 2004 Feb; 79(1):5-10. PubMed ID: 15223748
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer.
Kurakawa E; Shimamoto T; Utsumi K; Hirano T; Kato H; Ohyashiki K
Int J Oncol; 2001 Aug; 19(2):277-81. PubMed ID: 11445839
[TBL] [Abstract][Full Text] [Related]
14. In situ analysis of p16/INK4 promoter hypermethylation in esophageal carcinoma and gastric carcinoma.
Zhang F; Wang L; Wu PP; Yan ZW; Zheng L; Yu YY; Jiang XC
Chin J Dig Dis; 2004; 5(4):149-55. PubMed ID: 15612883
[TBL] [Abstract][Full Text] [Related]
15. Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus.
Lerma E; Esteller M; Herman JG; Prat J
Hum Pathol; 2002 Nov; 33(11):1120-5. PubMed ID: 12454817
[TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter methylation of p16(INK4a), RARB2 and SEMA3B in bronchial aspirates from patients with suspected lung cancer.
Grote HJ; Schmiemann V; Geddert H; Rohr UP; Kappes R; Gabbert HE; Böcking A
Int J Cancer; 2005 Sep; 116(5):720-5. PubMed ID: 15849750
[TBL] [Abstract][Full Text] [Related]
17. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
Roncalli M; Bianchi P; Bruni B; Laghi L; Destro A; Di Gioia S; Gennari L; Tommasini M; Malesci A; Coggi G
Hepatology; 2002 Aug; 36(2):427-32. PubMed ID: 12143052
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients.
Sharma G; Mirza S; Prasad CP; Srivastava A; Gupta SD; Ralhan R
Life Sci; 2007 Apr; 80(20):1873-81. PubMed ID: 17383681
[TBL] [Abstract][Full Text] [Related]
19. Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis.
Salvesen HB; Das S; Akslen LA
Clin Cancer Res; 2000 Jan; 6(1):153-9. PubMed ID: 10656444
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma.
van der Velden PA; Metzelaar-Blok JA; Bergman W; Monique H; Hurks H; Frants RR; Gruis NA; Jager MJ
Cancer Res; 2001 Jul; 61(13):5303-6. PubMed ID: 11431374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]